Retour
Fourchette du Jour
73,31 €
76,01 €
Fourchette 52 Semaines
19,45 €
103,00 €
Volume
596 547
Moyenne 50J / 200J
79,67 €
/
61,62 €
Clôture Précédente
76,96 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -19,5 | 0,3 |
| P/B | 3,9 | 2,9 |
| ROE % | -25,8 | 3,7 |
| Net Margin % | -794,4 | 3,8 |
| Rev Growth 5Y % | -14,4 | 10,0 |
| D/E | 0,1 | 0,2 |
Objectif de Cours des Analystes
Hold
117,31 €
+57.6%
Low: 90,00 €
High: 138,00 €
BPA Prévisionnel
-3,66 €
CA Est.
40 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
-3,41 €
-9,67 € – 0,66 €
|
220 M | 12 |
| FY2029 |
-4,31 €
-12,21 € – 0,84 €
|
54 M | 8 |
| FY2028 |
-4,10 €
-4,99 € – -3,09 €
|
43 M | 14 |
Points Clés
Revenue declined -14,35% annually over 5 years
Debt/Equity of 0,05 — conservative balance sheet
Negative free cash flow of -234,34M
Capital efficient — spends only 3,70% of revenue on capex
Croissance
Revenue Growth (5Y)
-14,35%
Revenue (1Y)-16,72%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-25,79%
ROIC-15,77%
Net Margin-794,39%
Op. Margin-891,33%
Sécurité
Debt / Equity
0,05
Current Ratio10,47
Interest Coverage-1403,21
Valorisation
P/E Ratio
-19,51
P/B Ratio3,85
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -16,72% | Revenue Growth (3Y) | -29,38% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -14,35% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 39,20M | Net Income (TTM) | -311,40M |
| ROE | -25,79% | ROA | -17,87% |
| Gross Margin | 100,00% | Operating Margin | -891,33% |
| Net Margin | -794,39% | Free Cash Flow (TTM) | -234,34M |
| ROIC | -15,77% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,05 | Current Ratio | 10,47 |
| Interest Coverage | -1403,21 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -19,51 | P/B Ratio | 3,85 |
| P/S Ratio | 155,00 | PEG Ratio | -0,89 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 6,08B | Enterprise Value | 5,80B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 39,20M | 47,07M | 78,59M | 46,83M | 72,83M |
| Net Income | -311,40M | -223,86M | -146,96M | -154,81M | -100,22M |
| EPS (Diluted) | -3,69 | -2,98 | -2,52 | -2,87 | -2,09 |
| Gross Profit | 39,20M | 47,07M | 78,59M | 46,83M | 72,83M |
| Operating Income | -349,40M | -261,64M | -165,53M | -161,26M | -100,53M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,74B | 978,04M | 575,76M | 603,13M | 605,91M |
| Total Liabilities | 163,15M | 142,42M | 180,79M | 112,98M | 146,27M |
| Shareholders' Equity | 1,58B | 835,62M | 394,97M | 490,15M | 459,64M |
| Total Debt | 82,25M | 87,76M | 84,67M | 17,34M | 17,96M |
| Cash & Equivalents | 357,01M | 120,26M | 109,97M | 68,40M | 47,98M |
| Current Assets | 871,21M | 510,27M | 405,32M | 419,42M | 451,27M |
| Current Liabilities | 83,21M | 67,77M | 85,69M | 71,34M | 92,54M |